From Roche’s $1.4 billion licensing deal to AstraZeneca’s presidential symposium and an avalanche of clinical readouts, antibody-drug conjugates dominated Europe’s leading cancer conference over the ...
Antibody–drug conjugates (ADCs) in oncology have been some of the most sought-after assets in the biopharma dealmaking landscape in the past two years. For example, in 2023, Pfizer purchased Seagen, ...
Explore how digital feedback controllers manage motors, pressure, temperature, and more, and learn why ADC and DAC performance are crucial when designing robust embedded systems. How to define the ...
While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...
After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, AbbVie is advancing its solid tumor ambitions with a new FDA green light.
Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...
Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the low ...
1 School of Automation and Information Engineering, Sichuan University of Science and Engineering, Yibin, China. 2 Sichuan Key Laboratory of Artificial Intelligence, Yibin, China. A 14-bit successive ...
[Igor] made a VU meter with LEDs using 8 LEDs and 8 comparators. This is a fast way to get one of 8 bits to indicate an input voltage, but that’s only the equivalent of a 3-bit analog to digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results